Biomedical engineers have created a biopolymer that can provide weeks of glucose control with a single injection. The new tool has the potential to replace daily or weekly insulin shots with bi-weekly ...
Hyperglycemia, or high levels of glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal blood sugar levels. Animal studies also pointed to ...
Please provide your email address to receive an email when new articles are posted on . Reaven and colleagues analyzed data from 1,655 veterans with type 2 diabetes randomly assigned to intensive (n = ...
We previously reported that a median of 5.6 years of intensive as compared with standard glucose lowering in 1791 military veterans with type 2 diabetes resulted in a risk of major cardiovascular ...
Hyperglycemia, or high levels of glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal blood sugar levels. Animal studies also pointed to ...
Managing blood sugar levels has become increasingly vital for overall health and well-being in today’s fast-paced world. With the rise of diabetes and related health issues, many individuals are ...
HONOLULU — Intense intravenous (IV) glucose control is no better than using standard subcutaneous "sliding scale" insulin for improving functional outcomes after an ischemic stroke — and may even ...
Real-time glucose control in cell culture bioprocesses achieved using Raman technology Product quality is optimized to the target product profile through Raman-based feedback control of glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results